CD274 and pancreatic neoplasm: When a study in 200 patients with various solid tumors (breast, lung, colon, prostate, and pancreatic cancers), interrogated PDL-1 levels before and after deglycosylation, it strikingly demonstarted a >2-fold increase in PDL1-positivity at 47.5% (by H-score) when deglycosylated PDL-1 was taken into account.